4th Annual International Gene Forum 2003 "50 Years of Double Helix"
12 August 2003 - 13 August 2003
The event incorporates Exhibition aimed at biotechnology-related companies, Connect Biobusiness Workshop, Bioethics Workshop. During the event will be held ScanBalt Bioregion Steering Committee meeting.
Biotechnology leads the way in medical innovation by confronting lifes most threatening illnesses. Hundreds of biotechnology drugs and vaccines are in human clinical trials and many more in early development. Nearly every human disease is under attack by thousands of dedicated researchers all over the world.
To date, the explosion of new data from the sequencing projects has yielded more questions than disease therapies, but that should change as genomics and proteomics researchers understanding of how molecules interact and respond to environmental stress grows when were healthy or sick.
The more than 20 speakers, include:
> Prof. Rolf M. Zinkernagel, Nobel Prize (1996), Institute of Experimental Immunology, University of Zurich, Switzerland; ,> Prof. Adriano Aguzzi (University of Zurich, Switzerland);,> Dr. Ruth Taylor (IBM Lifescience Solutions, USA);,> Dr. Duncan McHale (Pfizer Ltd, UK);,> Dr. John Newton (CEO, UK Biobank Project, UK); ,> Prof. Andres Metspalu (University of Tartu, Estonia); ,> Dr. Gavin Screaton (MRC Human Immunology Unit, UK);,> Leslie A. Platt, J.D. (Ernst&Young LLP, USA);,> Prof. Thomas Baldwin (University of York, UK Stem Cell Steering Committee, Nuffield Council of Bioethics, UK);,> Dr. Struan Grant (deCode Genetics, Iceland);,> Prof. Alan Wright (MRC, UK);,> Dr. Per Otteskog, (Karo Bio AB, Sweden);,> Prof. Rudi Westendorp (Leiden University, The Netherlands);,> Prof. Pierre Hainaut (IARC, France).
The registration deadline is September 5, 2003.
Further information:,http://www.geneforum.ee/GF2003/index.php,e-mail: geneforum@genomics.ee ,By phone at: +372 56 469 494
Biotechnology leads the way in medical innovation by confronting lifes most threatening illnesses. Hundreds of biotechnology drugs and vaccines are in human clinical trials and many more in early development. Nearly every human disease is under attack by thousands of dedicated researchers all over the world.
To date, the explosion of new data from the sequencing projects has yielded more questions than disease therapies, but that should change as genomics and proteomics researchers understanding of how molecules interact and respond to environmental stress grows when were healthy or sick.
The more than 20 speakers, include:
> Prof. Rolf M. Zinkernagel, Nobel Prize (1996), Institute of Experimental Immunology, University of Zurich, Switzerland; ,> Prof. Adriano Aguzzi (University of Zurich, Switzerland);,> Dr. Ruth Taylor (IBM Lifescience Solutions, USA);,> Dr. Duncan McHale (Pfizer Ltd, UK);,> Dr. John Newton (CEO, UK Biobank Project, UK); ,> Prof. Andres Metspalu (University of Tartu, Estonia); ,> Dr. Gavin Screaton (MRC Human Immunology Unit, UK);,> Leslie A. Platt, J.D. (Ernst&Young LLP, USA);,> Prof. Thomas Baldwin (University of York, UK Stem Cell Steering Committee, Nuffield Council of Bioethics, UK);,> Dr. Struan Grant (deCode Genetics, Iceland);,> Prof. Alan Wright (MRC, UK);,> Dr. Per Otteskog, (Karo Bio AB, Sweden);,> Prof. Rudi Westendorp (Leiden University, The Netherlands);,> Prof. Pierre Hainaut (IARC, France).
The registration deadline is September 5, 2003.
Further information:,http://www.geneforum.ee/GF2003/index.php,e-mail: geneforum@genomics.ee ,By phone at: +372 56 469 494